Menu Search
Equities

Luye Pharma Group Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert
2186:HKG.HZ

Luye Pharma Group Ltd

Actions
  • Price (HKD)2.45
  • Today's Change0.04 / 1.66%
  • Shares traded21.79m
  • 1 Year change+5.60%
  • Beta1.3691
Data delayed at least 15 minutes, as of Mar 05 2026 08:08 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Luye Pharma Group Ltd is a company mainly engaged in developing, producing, marketing and selling pharmaceutical products. The Company operates four segments, including Oncology Drugs segment, Cardiovascular System Drugs segment, Alimentary Tract and Metabolism Drugs segment, and Central Nervous System Drugs segment. The Oncology Drugs segment provides Lipusu, Boyounuo, Baituowei, CMNa and Mimeixin and other drugs. The Cardiovascular System Drugs segment provides Xuezhikang, Oukai and Maitongna and other drugs. The Alimentary Tract and Metabolism Drugs segment provides Bei Xi and other drugs. The Central Nervous System Drugs segment provides Seroquel, Ruoxinlin, Rykindo, Meibirui and Jinyouping and other drugs.

  • Revenue in HKD (TTM)6.98bn
  • Net income in HKD448.98m
  • Incorporated2003
  • Employees5.12k
  • Location
    Luye Pharma Group LtdNo.15 Chuangye RoadHigh-Tech Zone, YantaiYANTAI 264003ChinaCHN
  • Phone+86 5 356717618
  • Fax+86 5 356717718
  • Websitehttps://www.luye.cn/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.